HSBC

Multiplex cinema chain Cineworld is betting on rapid expansion as it pours more billions into another North American acquisition. Cineworld, which is among the most shorted companies in the UK, plans to acquire Canadian competitor Cineplex in a $2.1bn deal financed by debt. This plan comes nine months after it made a $3.6bn acquisition in the US.

Power company Electricité de France has agreed to buy back almost €1.2bn-equivalent of its hybrid capital bonds, marking the end of a busy period for the company in the debt markets.

Singapore’s CapitaLand Commercial Trust dove into the yen market this month to sell its inaugural green bond.

Ping An Group subsidiary OneConnect Financial Technology has raised $312m from a listing of American Depository Shares (ADS) after trimming and then increasing its IPO.

Investec has entered the loan market for the third time this year, taking a $450m two year term loan from a range of international lenders.

OneConnect Financial Technology Co, a unit of Chinese conglomerate Ping An Group, reduced the size and price range of its New York Stock Exchange listing on Wednesday, a day before it was to be priced.

Langham Hospitality Investments has closed a HK$7.5bn ($958m) sustainability-linked deal with 11 lenders, marking the first loan of its kind from the hospitality sector in Asia.

Sprawling e-commerce company The Hut Group completed a €600m term loan 'B' deal on Tuesday, changing its capital structure. The privately held company — touted as one of the few UK tech unicorns — has expansion ambitions in both online stores and web services, but is also making risky excursions into real estate.

JAB Holding, the consumer products holding company, steepened its credit curve this week with its dual tranche bond, as it preferred securing demand over squeezing investors on pricing.

Beijing Capital Land has set the ball rolling for a three tranche rights issue, eyeing around $361.5m from a deal combining its offshore and domestic shares.

Health and Happiness International Holdings, a China-based supplier of paediatric nutritional and baby care products, has increased the size of its loan to $675m on strong demand.

Venus Medtech (Hangzhou), a Chinese biotechnology company, has wrapped up its Hong Kong IPO at the top end of guidance, raking in HK$2.6bn ($311.1m).